2 results
Daliresp (Roflumilast) 
Indication: Reduce risk of COPD exacerbations 
Drug Class: Selective Phosphodiesterase-4 (PDE4) Inhibitor 
GOLD 2019
Indication: Reduce risk ... Drug Class: Selective ... Dosing: 250 mcg tablet ... to reduce the risk ... low, adding an ICS
Preoperative Risk Evaluation

Major Pre-Op Questions:
1. Does the patient have any modifiable risk factors that could be
Evaluation Major ... dependent DM ACS ... ASA class If ... algorithm to determine ... #Evaluation #stratification